Pios, Ailyn M.
HRN: 21-87-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2022
METRONIDAZOLE 500MG (TAB)
09/04/2022
09/11/2022
PO
500mg
Q8
Perianal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes